 ST. LOUIS, Sept. 09, 2021 GLOBE NEWSWIRE -- Stereotaxis NYSE: STXS, the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that David Fischel, Chairman and CEO, will present at two investor conferences in September 2021. 